OUTPUT COMMON MODE VOLTAGE STABILIZER OVER LARGE COMMON MODE INPUT RANGE IN A HIGH SPEED DIFFERENTIAL AMPLIFIER
    2.
    发明申请
    OUTPUT COMMON MODE VOLTAGE STABILIZER OVER LARGE COMMON MODE INPUT RANGE IN A HIGH SPEED DIFFERENTIAL AMPLIFIER 有权
    在高速差分放大器中通过大型通用模式输入范围输出通用模式电压稳压器

    公开(公告)号:US20110115561A1

    公开(公告)日:2011-05-19

    申请号:US12622167

    申请日:2009-11-19

    Abstract: A circuit includes a differential amplifier having a folded cascode architecture with a pair of cascode transistors. A sensing circuit senses a common mode input voltage of a differential input signal applied to the differential amplifier. A bias generator circuit generates a bias voltage for application to the pair of cascode transistors in the folded cascode architecture. The bias generator circuit is connected to an output of the sensing circuit such that the generated bias voltage has a value which is dependent on the sensed common mode input voltage. This dependence stabilizes a common mode output voltage from the differential amplifier in response to changes in the common mode input voltage.

    Abstract translation: 电路包括具有折叠共源共栅结构的差分放大器和一对共源共栅晶体管。 感测电路感测施加到差分放大器的差分输入信号的共模输入电压。 偏置发生器电路在折叠共源共栅结构中产生用于施加到该对共源共栅晶体管的偏置电压。 偏置发生器电路连接到感测电路的输出,使得产生的偏置电压具有取决于感测到的共模输入电压的值。 这种依赖性响应于共模输入电压的变化而稳定来自差分放大器的共模输出电压。

    Extended duration antacid product
    3.
    发明授权
    Extended duration antacid product 失效
    延长使用时间的抗酸产品

    公开(公告)号:US5490985A

    公开(公告)日:1996-02-13

    申请号:US210645

    申请日:1994-03-18

    CPC classification number: A61K9/1272 A61K33/10

    Abstract: An antacid product having extended duration of residence in the gastric and upper intestinal systems has been developed. This antacid product includes a blend of 10-70% by volume nonphospholipid lipid vesicles, with a particulate base. An antiflatulence agent may also be included. A method of providing extended duration amelioration of acid build up in the gastric and upper intestinal tract using this product is also disclosed.

    Abstract translation: 已经开发了在胃和上肠系统中延长持续时间的抗酸产品。 该抗酸产品包括10-70体积%的非脂质脂质囊泡与颗粒基质的混合物。 还可以包括抗溢流剂。 还公开了使用该产品在胃和上肠道中延长持续时间改善酸积累的方法。

    EXTENSIBILITY FRAMEWORK OF A NETWORK ELEMENT
    4.
    发明申请
    EXTENSIBILITY FRAMEWORK OF A NETWORK ELEMENT 审中-公开
    网络元素的可扩展框架

    公开(公告)号:US20090288104A1

    公开(公告)日:2009-11-19

    申请号:US12123225

    申请日:2008-05-19

    Abstract: Techniques for providing extensibility framework for processing network packets are described herein. In one embodiment, in response to a packet received at a network element, the packet is processed using a generic process for performing a first type of operations required by the packet, wherein the first type of operations is common to a type of the packet. An extended process is invoked, via an extensibility application programming interface (API), to perform a custom operation that is not common to the generic process and is not statically known to the generic process, in order to determine whether the packet is eligible to access a resource of at least one of a plurality of application servers of a datacenter, including a layer-7 access control process. The network element operates as an application service gateway for the datacenter. Other methods and apparatuses are also described.

    Abstract translation: 本文描述了用于提供用于处理网络分组的可扩展性框架的技术。 在一个实施例中,响应于在网络元件处接收到的分组,使用用于执行分组所需的第一类型的操作的通用处理来处理分组,其中第一类型的操作对于分组的类型是共同的。 通过可扩展性应用程序编程接口(API)调用扩展过程,以执行通用过程不常见的定制操作,并且通用过程不是静态知道的,以便确定数据包是否有资格访问 数据中心的多个应用服务器中的至少一个的资源,包括第7层访问控制过程。 网络元件作为数据中心的应用服务网关运行。 还描述了其它方法和装置。

    Method of inhibiting viral reproduction using non-phospholipid,
paucilamellar liposomes
    5.
    发明授权
    Method of inhibiting viral reproduction using non-phospholipid, paucilamellar liposomes 失效
    使用非磷脂,薄膜脂质体抑制病毒繁殖的方法

    公开(公告)号:US5561062A

    公开(公告)日:1996-10-01

    申请号:US265506

    申请日:1994-06-24

    CPC classification number: A61K9/1272

    Abstract: A new method of inactivating enveloped viruses and preparations useful in accomplishing this inactivation are disclosed. The method is based on the discovery that paucilamellar lipid vesicles, preferably having non-phospholipids as their primary structural material, can fuse with enveloped virus and that the nucleic acid of the virus denatures shortly after the fusion. The method is useful for inactivating viruses such as orthomyxoviruses, paramyxoviruses, coronaviruses, and retroviruses.

    Abstract translation: 公开了一种灭活包封的病毒和用于实现该失活的制剂的新方法。 该方法基于以下发现:优选具有非磷脂作为其主要结构材料的薄膜脂质囊泡可以与包膜病毒融合,并且病毒的核酸在融合后不久变性。 该方法可用于灭活病毒如正粘病毒,副粘病毒,冠状病毒和逆转录病毒。

Patent Agency Ranking